Browse drugs

…for systemic sclerosis (SSc) treatment, which newly recommended mycophenolate mofetil (MMF), rituximab (RTX), and tocilizumab (TCZ) as options for sk…

… (SLE) is an autoimmune disease driven by B-cell dysregulation. Rituximab (RTX) depletes B cells through complement-dependent cytotoxicit…

…the effectiveness and safety profiles of obinutuzumab (OBZ) and rituximab (RTX) in patients with NPSLE.Methods Patients with new-onset NP…

…patients with autoimmune rheumatic diseases (AIRD) treated with rituximab (RTX).Methods Single-centre, retrospective cohort study of pati…

…nation treatment with mycophenolate and rituximab (MMF-RTX) vs. rituximab monotherapy (RTX) in a single-center cohort of patients affecte…

…20 monoclonal antibody that has demonstrated its superiority to rituximab (RTX) in vitro and in vivo. Our assumption is that a single inf…

…through CMR. Based on recent evidence, combination therapy with rituximab (RTX, 2 x 1000 mg with a two-week gap and a repeat dose after s…

…. The mean disease duration was 7.4±6.4 years. All pts received prednisolone at mean dose of 10±4 mg/day. 11% of patients received cyclophos…

…atified according to anti-SS-A antibody status, and response to tocilizumab (TCZ) or rituximab (RTX) was evaluated.Results Among 212 cases,…

…11), antimalarials (n= 55), tacrolimus (n= 27), everolimus (1), belimumab (BLM) (19) and anifrolumab (1). After a follow-up of 59.7±46 mo…

…atients studied, 90(30%) underwent non-medical switch, Group 1 [RTX-O to RTX-B=68%; between biosimilars=32%]. Their mean (SD) age was…

… this small real-world cohort of RTX-refractory/intolerant SLE, OBZ yielded promising responses, including in lupus nephritis, with…